Trial Profile
Study of dapagliflozin combined with other oral hypoglycemic agents in type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 27 Sep 2018 New trial record
- 01 Aug 2018 Results published in the Diabetes Research and Clinical Practice